Published: Aug-2022|  Format: PDF | QY Research |  Number of pages: 111 | Code: MBI-1635536

Narcotic (Opioid) Drugs Market by Products (Codeine, Fentanyl, Hydrocodone, Hydromorphone), by Applications (Pain Relief Application, Anesthesia Application) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 - 2028

Select a Format




 Buy Now

The Global Narcotic (Opioid) Drugs Market was valued at USD XXX in 2022 and it is projected to surpass around USD XX by 2030 with a registered CAGR of xxx during the forecast period 2022 to 2030.

Growth factor

Our new latest report titled, global Narcotic (Opioid) Drugs Market comes up with comprehensive analysis of the industry including emerging trends and current development of the market. The report offers comprehensive insights of the industry with details of market share, size, revenue, growth opportunities, regional insights and major companies. The report provides all necessary and vital information related to the global market to help the buyer, the readers, investors get a complete understanding of the market and invest accordingly to the upcoming challenges and opportunities.

List of Key Players Operating in the Market:

The report provides in-depth research about each player operating in the global Narcotic (Opioid) Drugs Market along with its worldwide financial position, previous and upcoming business expansion plans, new product launches. The upcoming activities of the key players related to various strategies such as acquisitions, partnerships, mergers and, joint ventures, research and development investments.

  • Pfizer
  • Teva
  • Purdue Pharma
  • Mallinckrodt
  • Amneal Pharma
  • Collegium
  • Johnson & Johnson
  • Merck
  • Mylan
  • Hikma Pharmaceuticals
  • Sun Pharma
  • Endo Pharmaceuticals
  • Allergan

Market research report presents an analysis of all the data collected through primary and secondary resources. Our well experienced team of analyst collects all the information from several leading entities press release, government publication sources such as gold standard, silver standard, white papers, articles and websites, corporate filings including financial statements, annual reports, investor presentations, etc.

Our Report offers detailed insights market valuation, volume, share, outlook, production capacity and price analysis for the forecast period 2022-2030. Furthermore, the study also includes market segmentation on the basis of product, application, end-users, supply chain, distribution channel and other segment. Additionally, the study also includes market segmentation based on upstream downstream demand analysis, feedstock, and consumption rate and market share. It employs both primary and secondary methods of data collection to obtain relevant and sustainable information of the market.

This exclusive report includes detailed information about the market related activities such as Partnerships, stake holder position, Sole Traders, which create, develop, and conduct activities for the study and analysis of markets as per the customization and specifications of the client.

Segment Analysis of the Market:

The objective of the report mainly provides an essential overview of the Narcotic (Opioid) Drugs Market with detailed market segmentation by product, end-users, distribution channel, technology, content, type, application and region. The global market is expected to witness rapid growth during the forecast period. The report provides growth drivers, challenges, restraints of the region. It also offers the fastest growing segment with future scope, advancement emerging trends. The study examines the global scenario of the market by conducting an economy-wide assessment along with a comprehensive study involving product costs, drivers and restrictions, demands, profit analysis, production, distribution, and year-on-year growth rates.

By Type

  • Codeine
  • Fentanyl
  • Hydrocodone
  • Hydromorphone
  • Meperidine
  • Methadone
  • Others

By Application

  • Pain Relief Application
  • Anesthesia Application

Key Question Answered in this In-depth Market Report 2022-2028:

  • What was the market valued in the past year?
  • What will be the projected size, share and CAGR of the market?
  • What was the market status across the globe?
  • What are the profit margins in global Narcotic (Opioid) Drugs Market?
  • What are the growth factors boosts the market for the forecast period?
  • Which segment is going to boom in the near future?
  • What are the upcoming trends of the market?
  • Who are the key companies or players of the market?
  • Which is the fastest growing region of the global Narcotic (Opioid) Drugs Market?

Regional Insights:

The government initiative increasing the development activities of the Narcotic (Opioid) Drugs Market. On the other hand the major reason behind the growth is the market key players are expanding their operation in this region.

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Exclusive Report Offers:

  1. To study and analyze the global Narcotic (Opioid) Drugs Market consumption rate by key regions, type and application, historical data from past five years, and for upcoming years.
  2. The global research study look at the market to identify key influencing factors and entry barriers.
  3. To understand the structure of market by identifying and studying its various segments.
  4. To analyze with respect to individual prospects, growth factors, emerging trends, and their contribution to the whole market.
  5. Study focuses on the analysis of key players, to describe and analyze the sales volume, company size, share, value, market competition landscape, SWOT analysis and development plans in the near future.
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Narcotic (Opioid) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Codeine
        1.2.3 Fentanyl
        1.2.4 Hydrocodone
        1.2.5 Hydromorphone
        1.2.6 Meperidine
        1.2.7 Methadone
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Narcotic (Opioid) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Pain Relief Application
        1.3.3 Anesthesia Application
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Narcotic (Opioid) Drugs Market Perspective (2017-2028)
    2.2 Narcotic (Opioid) Drugs Growth Trends by Region
        2.2.1 Narcotic (Opioid) Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Narcotic (Opioid) Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Narcotic (Opioid) Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Narcotic (Opioid) Drugs Market Dynamics
        2.3.1 Narcotic (Opioid) Drugs Industry Trends
        2.3.2 Narcotic (Opioid) Drugs Market Drivers
        2.3.3 Narcotic (Opioid) Drugs Market Challenges
        2.3.4 Narcotic (Opioid) Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Narcotic (Opioid) Drugs Players by Revenue
        3.1.1 Global Top Narcotic (Opioid) Drugs Players by Revenue (2017-2022)
        3.1.2 Global Narcotic (Opioid) Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Narcotic (Opioid) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Narcotic (Opioid) Drugs Revenue
    3.4 Global Narcotic (Opioid) Drugs Market Concentration Ratio
        3.4.1 Global Narcotic (Opioid) Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Narcotic (Opioid) Drugs Revenue in 2021
    3.5 Narcotic (Opioid) Drugs Key Players Head office and Area Served
    3.6 Key Players Narcotic (Opioid) Drugs Product Solution and Service
    3.7 Date of Enter into Narcotic (Opioid) Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Narcotic (Opioid) Drugs Breakdown Data by Type
    4.1 Global Narcotic (Opioid) Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2023-2028)
5 Narcotic (Opioid) Drugs Breakdown Data by Application
    5.1 Global Narcotic (Opioid) Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Narcotic (Opioid) Drugs Market Size (2017-2028)
    6.2 North America Narcotic (Opioid) Drugs Market Size by Type
        6.2.1 North America Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
        6.2.2 North America Narcotic (Opioid) Drugs Market Size by Type (2023-2028)
        6.2.3 North America Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
    6.3 North America Narcotic (Opioid) Drugs Market Size by Application
        6.3.1 North America Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
        6.3.2 North America Narcotic (Opioid) Drugs Market Size by Application (2023-2028)
        6.3.3 North America Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
    6.4 North America Narcotic (Opioid) Drugs Market Size by Country
        6.4.1 North America Narcotic (Opioid) Drugs Market Size by Country (2017-2022)
        6.4.2 North America Narcotic (Opioid) Drugs Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Narcotic (Opioid) Drugs Market Size (2017-2028)
    7.2 Europe Narcotic (Opioid) Drugs Market Size by Type
        7.2.1 Europe Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Narcotic (Opioid) Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
    7.3 Europe Narcotic (Opioid) Drugs Market Size by Application
        7.3.1 Europe Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Narcotic (Opioid) Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
    7.4 Europe Narcotic (Opioid) Drugs Market Size by Country
        7.4.1 Europe Narcotic (Opioid) Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Narcotic (Opioid) Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type
        8.2.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application
        8.3.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region
        8.4.1 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Narcotic (Opioid) Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Narcotic (Opioid) Drugs Market Size (2017-2028)
    9.2 Latin America Narcotic (Opioid) Drugs Market Size by Type
        9.2.1 Latin America Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Narcotic (Opioid) Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
    9.3 Latin America Narcotic (Opioid) Drugs Market Size by Application
        9.3.1 Latin America Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Narcotic (Opioid) Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
    9.4 Latin America Narcotic (Opioid) Drugs Market Size by Country
        9.4.1 Latin America Narcotic (Opioid) Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Narcotic (Opioid) Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type
        10.2.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Narcotic (Opioid) Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application
        10.3.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Narcotic (Opioid) Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country
        10.4.1 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Narcotic (Opioid) Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Details
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Narcotic (Opioid) Drugs Introduction
        11.1.4 Pfizer Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
        11.1.5 Pfizer Recent Developments
    11.2 Teva
        11.2.1 Teva Company Details
        11.2.2 Teva Business Overview
        11.2.3 Teva Narcotic (Opioid) Drugs Introduction
        11.2.4 Teva Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
        11.2.5 Teva Recent Developments
    11.3 Purdue Pharma
        11.3.1 Purdue Pharma Company Details
        11.3.2 Purdue Pharma Business Overview
        11.3.3 Purdue Pharma Narcotic (Opioid) Drugs Introduction
        11.3.4 Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
        11.3.5 Purdue Pharma Recent Developments
    11.4 Mallinckrodt
        11.4.1 Mallinckrodt Company Details
        11.4.2 Mallinckrodt Business Overview
        11.4.3 Mallinckrodt Narcotic (Opioid) Drugs Introduction
        11.4.4 Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
        11.4.5 Mallinckrodt Recent Developments
    11.5 Amneal Pharma
        11.5.1 Amneal Pharma Company Details
        11.5.2 Amneal Pharma Business Overview
        11.5.3 Amneal Pharma Narcotic (Opioid) Drugs Introduction
        11.5.4 Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
        11.5.5 Amneal Pharma Recent Developments
    11.6 Collegium
        11.6.1 Collegium Company Details
        11.6.2 Collegium Business Overview
        11.6.3 Collegium Narcotic (Opioid) Drugs Introduction
        11.6.4 Collegium Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
        11.6.5 Collegium Recent Developments
    11.7 Johnson & Johnson
        11.7.1 Johnson & Johnson Company Details
        11.7.2 Johnson & Johnson Business Overview
        11.7.3 Johnson & Johnson Narcotic (Opioid) Drugs Introduction
        11.7.4 Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
        11.7.5 Johnson & Johnson Recent Developments
    11.8 Merck
        11.8.1 Merck Company Details
        11.8.2 Merck Business Overview
        11.8.3 Merck Narcotic (Opioid) Drugs Introduction
        11.8.4 Merck Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
        11.8.5 Merck Recent Developments
    11.9 Mylan
        11.9.1 Mylan Company Details
        11.9.2 Mylan Business Overview
        11.9.3 Mylan Narcotic (Opioid) Drugs Introduction
        11.9.4 Mylan Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
        11.9.5 Mylan Recent Developments
    11.10 Hikma Pharmaceuticals
        11.10.1 Hikma Pharmaceuticals Company Details
        11.10.2 Hikma Pharmaceuticals Business Overview
        11.10.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Introduction
        11.10.4 Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
        11.10.5 Hikma Pharmaceuticals Recent Developments
    11.11 Sun Pharma
        11.11.1 Sun Pharma Company Details
        11.11.2 Sun Pharma Business Overview
        11.11.3 Sun Pharma Narcotic (Opioid) Drugs Introduction
        11.11.4 Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
        11.11.5 Sun Pharma Recent Developments
    11.12 Endo Pharmaceuticals
        11.12.1 Endo Pharmaceuticals Company Details
        11.12.2 Endo Pharmaceuticals Business Overview
        11.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Introduction
        11.12.4 Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
        11.12.5 Endo Pharmaceuticals Recent Developments
    11.13 Allergan
        11.13.1 Allergan Company Details
        11.13.2 Allergan Business Overview
        11.13.3 Allergan Narcotic (Opioid) Drugs Introduction
        11.13.4 Allergan Revenue in Narcotic (Opioid) Drugs Business (2017-2022)
        11.13.5 Allergan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables Table 1. Global Narcotic (Opioid) Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Codeine Table 3. Key Players of Fentanyl Table 4. Key Players of Hydrocodone Table 5. Key Players of Hydromorphone Table 6. Key Players of Meperidine Table 7. Key Players of Methadone Table 8. Key Players of Others Table 9. Global Narcotic (Opioid) Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 10. Global Narcotic (Opioid) Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 11. Global Narcotic (Opioid) Drugs Market Size by Region (2017-2022) & (US$ Million) Table 12. Global Narcotic (Opioid) Drugs Market Share by Region (2017-2022) Table 13. Global Narcotic (Opioid) Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 14. Global Narcotic (Opioid) Drugs Market Share by Region (2023-2028) Table 15. Narcotic (Opioid) Drugs Market Trends Table 16. Narcotic (Opioid) Drugs Market Drivers Table 17. Narcotic (Opioid) Drugs Market Challenges Table 18. Narcotic (Opioid) Drugs Market Restraints Table 19. Global Narcotic (Opioid) Drugs Revenue by Players (2017-2022) & (US$ Million) Table 20. Global Narcotic (Opioid) Drugs Revenue Share by Players (2017-2022) Table 21. Global Top Narcotic (Opioid) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2021) Table 22. Ranking of Global Top Narcotic (Opioid) Drugs Companies by Revenue (US$ Million) in 2021 Table 23. Global 5 Largest Players Market Share by Narcotic (Opioid) Drugs Revenue (CR5 and HHI) & (2017-2022) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Narcotic (Opioid) Drugs Product Solution and Service Table 26. Date of Enter into Narcotic (Opioid) Drugs Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million) Table 29. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2017-2022) Table 30. Global Narcotic (Opioid) Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 31. Global Narcotic (Opioid) Drugs Revenue Market Share by Type (2023-2028) Table 32. Global Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million) Table 33. Global Narcotic (Opioid) Drugs Revenue Share by Application (2017-2022) Table 34. Global Narcotic (Opioid) Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 35. Global Narcotic (Opioid) Drugs Revenue Share by Application (2023-2028) Table 36. North America Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million) Table 37. North America Narcotic (Opioid) Drugs Market Size by Type (2023-2028) & (US$ Million) Table 38. North America Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million) Table 39. North America Narcotic (Opioid) Drugs Market Size by Application (2023-2028) & (US$ Million) Table 40. North America Narcotic (Opioid) Drugs Market Size by Country (2017-2022) & (US$ Million) Table 41. North America Narcotic (Opioid) Drugs Market Size by Country (2023-2028) & (US$ Million) Table 42. Europe Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million) Table 43. Europe Narcotic (Opioid) Drugs Market Size by Type (2023-2028) & (US$ Million) Table 44. Europe Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million) Table 45. Europe Narcotic (Opioid) Drugs Market Size by Application (2023-2028) & (US$ Million) Table 46. Europe Narcotic (Opioid) Drugs Market Size by Country (2017-2022) & (US$ Million) Table 47. Europe Narcotic (Opioid) Drugs Market Size by Country (2023-2028) & (US$ Million) Table 48. Asia Pacific Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million) Table 49. Asia Pacific Narcotic (Opioid) Drugs Market Size by Type (2023-2028) & (US$ Million) Table 50. Asia Pacific Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million) Table 51. Asia Pacific Narcotic (Opioid) Drugs Market Size by Application (2023-2028) & (US$ Million) Table 52. Asia Pacific Narcotic (Opioid) Drugs Market Size by Region (2017-2022) & (US$ Million) Table 53. Asia Pacific Narcotic (Opioid) Drugs Market Size by Region (2023-2028) & (US$ Million) Table 54. Latin America Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million) Table 55. Latin America Narcotic (Opioid) Drugs Market Size by Type (2023-2028) & (US$ Million) Table 56. Latin America Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million) Table 57. Latin America Narcotic (Opioid) Drugs Market Size by Application (2023-2028) & (US$ Million) Table 58. Latin America Narcotic (Opioid) Drugs Market Size by Country (2017-2022) & (US$ Million) Table 59. Latin America Narcotic (Opioid) Drugs Market Size by Country (2023-2028) & (US$ Million) Table 60. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Type (2017-2022) & (US$ Million) Table 61. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Type (2023-2028) & (US$ Million) Table 62. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Application (2017-2022) & (US$ Million) Table 63. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Application (2023-2028) & (US$ Million) Table 64. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Country (2017-2022) & (US$ Million) Table 65. Middle East and Africa Narcotic (Opioid) Drugs Market Size by Country (2023-2028) & (US$ Million) Table 66. Pfizer Company Details Table 67. Pfizer Business Overview Table 68. Pfizer Narcotic (Opioid) Drugs Product Table 69. Pfizer Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Table 70. Pfizer Recent Developments Table 71. Teva Company Details Table 72. Teva Business Overview Table 73. Teva Narcotic (Opioid) Drugs Product Table 74. Teva Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Table 75. Teva Recent Developments Table 76. Purdue Pharma Company Details Table 77. Purdue Pharma Business Overview Table 78. Purdue Pharma Narcotic (Opioid) Drugs Product Table 79. Purdue Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Table 80. Purdue Pharma Recent Developments Table 81. Mallinckrodt Company Details Table 82. Mallinckrodt Business Overview Table 83. Mallinckrodt Narcotic (Opioid) Drugs Product Table 84. Mallinckrodt Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Table 85. Mallinckrodt Recent Developments Table 86. Amneal Pharma Company Details Table 87. Amneal Pharma Business Overview Table 88. Amneal Pharma Narcotic (Opioid) Drugs Product Table 89. Amneal Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Table 90. Amneal Pharma Recent Developments Table 91. Collegium Company Details Table 92. Collegium Business Overview Table 93. Collegium Narcotic (Opioid) Drugs Product Table 94. Collegium Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Table 95. Collegium Recent Developments Table 96. Johnson & Johnson Company Details Table 97. Johnson & Johnson Business Overview Table 98. Johnson & Johnson Narcotic (Opioid) Drugs Product Table 99. Johnson & Johnson Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Table 100. Johnson & Johnson Recent Developments Table 101. Merck Company Details Table 102. Merck Business Overview Table 103. Merck Narcotic (Opioid) Drugs Product Table 104. Merck Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Table 105. Merck Recent Developments Table 106. Mylan Company Details Table 107. Mylan Business Overview Table 108. Mylan Narcotic (Opioid) Drugs Product Table 109. Mylan Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Table 110. Mylan Recent Developments Table 111. Hikma Pharmaceuticals Company Details Table 112. Hikma Pharmaceuticals Business Overview Table 113. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product Table 114. Hikma Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Table 115. Hikma Pharmaceuticals Recent Developments Table 116. Sun Pharma Company Details Table 117. Sun Pharma Business Overview Table 118. Sun Pharma Narcotic (Opioid) Drugs Product Table 119. Sun Pharma Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Table 120. Sun Pharma Recent Developments Table 121. Endo Pharmaceuticals Company Details Table 122. Endo Pharmaceuticals Business Overview Table 123. Endo Pharmaceuticals Narcotic (Opioid) Drugs Product Table 124. Endo Pharmaceuticals Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Table 125. Endo Pharmaceuticals Recent Developments Table 126. Allergan Company Details Table 127. Allergan Business Overview Table 128. Allergan Narcotic (Opioid) Drugs Product Table 129. Allergan Revenue in Narcotic (Opioid) Drugs Business (2017-2022) & (US$ Million) Table 130. Allergan Recent Developments Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Global Narcotic (Opioid) Drugs Market Share by Type: 2021 VS 2028 Figure 2. Codeine Features Figure 3. Fentanyl Features Figure 4. Hydrocodone Features Figure 5. Hydromorphone Features Figure 6. Meperidine Features Figure 7. Methadone Features Figure 8. Others Features Figure 9. Global Narcotic (Opioid) Drugs Market Share by Application: 2021 VS 2028 Figure 10. Pain Relief Application Case Studies Figure 11. Anesthesia Application Case Studies Figure 12. Narcotic (Opioid) Drugs Report Years Considered Figure 13. Global Narcotic (Opioid) Drugs Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 14. Global Narcotic (Opioid) Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Narcotic (Opioid) Drugs Market Share by Region: 2021 VS 2028 Figure 16. Global Narcotic (Opioid) Drugs Market Share by Players in 2021 Figure 17. Global Top Narcotic (Opioid) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcotic (Opioid) Drugs as of 2021) Figure 18. The Top 10 and 5 Players Market Share by Narcotic (Opioid) Drugs Revenue in 2021 Figure 19. North America Narcotic (Opioid) Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 20. North America Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2028) Figure 21. North America Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2028) Figure 22. North America Narcotic (Opioid) Drugs Market Size Share by Country (2017-2028) Figure 23. United States Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Canada Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Europe Narcotic (Opioid) Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 26. Europe Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2028) Figure 27. Europe Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2028) Figure 28. Europe Narcotic (Opioid) Drugs Market Size Share by Country (2017-2028) Figure 29. Germany Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. France Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. U.K. Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Italy Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Russia Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Nordic Countries Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Asia-Pacific Narcotic (Opioid) Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 36. Asia Pacific Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2028) Figure 37. Asia Pacific Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2028) Figure 38. Asia Pacific Narcotic (Opioid) Drugs Market Size Share by Region (2017-2028) Figure 39. China Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Japan Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. South Korea Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Southeast Asia Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. India Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Australia Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 45. Latin America Narcotic (Opioid) Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 46. Latin America Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2028) Figure 47. Latin America Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2028) Figure 48. Latin America Narcotic (Opioid) Drugs Market Size Share by Country (2017-2028) Figure 49. Mexico Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 50. Brazil Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Middle East & Africa Narcotic (Opioid) Drugs Market Size YoY (2017-2028) & (US$ Million) Figure 52. Middle East and Africa Narcotic (Opioid) Drugs Market Size Market Share by Type (2017-2028) Figure 53. Middle East and Africa Narcotic (Opioid) Drugs Market Size Market Share by Application (2017-2028) Figure 54. Middle East and Africa Narcotic (Opioid) Drugs Market Size Share by Country (2017-2028) Figure 55. Turkey Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Saudi Arabia Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. UAE Narcotic (Opioid) Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 58. Pfizer Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022) Figure 59. Teva Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022) Figure 60. Purdue Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022) Figure 61. Mallinckrodt Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022) Figure 62. Amneal Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022) Figure 63. Collegium Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022) Figure 64. Johnson & Johnson Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022) Figure 65. Merck Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022) Figure 66. Mylan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022) Figure 67. Hikma Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022) Figure 68. Sun Pharma Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022) Figure 69. Endo Pharmaceuticals Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022) Figure 70. Allergan Revenue Growth Rate in Narcotic (Opioid) Drugs Business (2017-2022) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed



Inquiry before buying

Request Sample

Request for Discount

Latest News

Global UAV Propulsion System Market to Grow at a (CAGR) of 11.8% during the Forecast Period 2022-2030

26-Sep-2022 | Semiconductor

As specified in the market business insights exclusive report, the global UAV Propulsion System Market is projected to reach USD 34,258.31 million by 2030. Growth Drivers: Market dynamics are the forces that influence the prices and b ...

Global Autonomous Vehicle Simulation Solution Market to Grow at a (CAGR) of 12.8% during the Forecast Period 2022-2030

24-Sep-2022 | Automobile

As specified in our exclusive report, the global Autonomous Vehicle Simulation Solution Market is projected to reach USD 2,515 Million by 2030. Growth Drivers: Increasing adoption of connected ve ...

Global Active Space Debris Removal Market to Grow at a (CAGR) of 23.9% during the Forecast Period 2022-2030

23-Sep-2022 | Aerospace & Defense

As specified in our exclusive report, the Global  Active Space Debris Removal Market size is projected to reach USD 452.65 million by 2030. According to the European Space Agency (ESA), there have been more than 5,000 launches into space ...

Global Small Arms Market to Grow at a (CAGR) of 4.8% during the Forecast Period 2022-2030

22-Sep-2022 | Aerospace & Defense

As specified in our exclusive report, the Global Small Arms Market is projected to reach USD 12.88 billion by 2030. The defense sector is upgrading weapons and ammunition and adopting more modern weapon systems, and deployments at military bases, i ...

Global RFID in Healthcare Market to Grow at a (CAGR) of 21.5% during the Forecast Period 2022-2030

21-Sep-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the Global RFID in Healthcare Market is projected to reach USD 12.06 billion by 2030. How RFID is Use in Healthcare Market? RFID applications in healthcare have been positi ...

More News...